Irritable Bowel Syndrome–A Potentially New Treatment at Last? – (06-28-00)

Irritable Bowel Syndrome–A Potentially New Treatment at Last?

They need to rephrase the title. The authors mean a new PHARMACEUTICAL treatment, because there have been many ways to treat IBS from a natural medicine standpoint using probiotics and diet as a start.

These studies provide encouraging news that tegaserod, by accelerating orocecal transit and especially colonic transit, may prove to be a benefit in patients with constipation-predominant IBS. It is obvious that further clinical studies on intestinal transit and secretion as well as the overall clinical efficacy of tegaserod in IBS are necessary. Nevertheless, this drug seems to have promise for patients with IBS.